GlaxoSmithKline and Abbott to start production in Ukraine
28 March 2013
UK pharma giant GlaxoSmithKline and the USA’s Abbott are considering launching production of their drugs in Ukraine at the facilities of Indar, one of Ukraine’s largest pharmaceutical producers, owned by the state.
Eisai joins trend to enter Russian pharma market, with Halaven launch
27 March 2013
Japanese drug major Eisai unit, has announced it is expanding its operations by establishing a new sales and marketing operation in Russia, a market that has seen a great deal attention from multinational pharmaceutical companies in recent times.
Amendments to drug registration law in Russia: Implications for the future
26 March 2013
The eagerly awaited draft amendments to the federal law, as well as Article 333.32.1, part two of the tax code of the Russian Federation, were published for consultation by the country’s Ministry of Health in late January this year. The amendments proved to be a mixed bag.
Expert team publishes International Declaration after Open Innovations International Forum
22 March 2013
The panel consisting of the well-known venture capitalists, managers of the world-leading universities, market analysts, and representatives of Russian development institutes prepared the International Declaration on the Forum "Open Innovation 2012".
Can Russia repeat last year’s GDP growth?
18 March 2013
Russia led the G-8 and ranked second among BRICS countries in terms of economic growth rates in 2012. Experts make guesses whether Moscow will be able to replicate its performance in 2013.
Health Ministry Proposes Drug Registration System
17 March 2013
The Health Ministry wants to create a database for controlling medicine sold in drug stores across the country.
Ukrainian government to simplify procedure for registration of imported drugs
17 March 2013
The government of Ukraine plans to simplify the procedure of registration of drugs, imported to the country from the European Union. According to an official representative of the Ukrainian State Drugs Service, all the companies, whose drugs are registered by the European Medicines Agency will pass the procedure for their registration in Ukraine only by filing a single application to the country’s Ministry of Health.
Science and Technology cooperation to grow between India and Russia
15 March 2013
There is a gamut of bilateral links and inter-governmental mechanisms in diverse science and technology sectors beyond defence and nuclear power.
Biologics Research Promises to Bolster the Future of Medicine
14 March 2013
America’s biopharmaceutical research companies are using biological processes to develop 907 medicines and vaccines targeting more than 100 diseases. Many biologics are made from a variety of natural sources—human, animal or microorganisms. Like small-molecule drugs, some biologics are intended to treat diseases and medical conditions. Other biologics are used to prevent or diagnose disease.
14 March 2013
America’s biopharmaceutical research companies are using biological processes to develop 907 medicines and vaccines targeting more than 100 diseases, according to a new report from PhRMA. The medicines and vaccines – all in human clinical trials or under review the U.S. Food and Drug Administration (FDA) – include 338 monoclonal antibodies, 250 vaccines, 93 recombinant proteins, 60 cell therapies, 46 gene therapies and 30 antisense medicines.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
Enhancing spectroscopy analysis with machine learning
03 February 2025
The production of new Russian “super antibiotic” to begin in Novosibirsk
03 February 2025
A Russian company has started producing 4 veterinary vaccines
31 January 2025
The government held its first meeting on the “New technologies for preserving health” project
31 January 2025